US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

707.58

+21.903.19%

Number of Gainers:72

Number of Losers:73

Number of Flat:9

PE:- -

High:707.93

Open:685.68

Low:683.13

Close:685.75

Volume:206.64M

Turnover:6.73B

Market Cap:493.09B

Float Cap:374.45B

Loading ...

Local Bounti Q2 Revenue Rises on Higher Production and Sales

Press Release: Nexxen Reports Record Second Quarter 2026 Financial Results

Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates

Unicycive Therapeutics Q2 EPS USD -0.06

THOMSON REUTERS

Unicycive Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS

Unicycive Therapeutics - Q2 Net Loss was $1.70 Mln or $0.06 Per Share

THOMSON REUTERS

Similarweb Q2 Revenue USD 77.186 Million Vs. IBES Estimate USD 75.5 Million

Similarweb Beats Q2 Estimates on AI Demand, Lifts FY Outlook

Sutro Biopharma Q2 Revenue Misses Estimates, Posts Wider Loss

BTIG Adjusts Price Target on AppLovin to $408 From $574, Keeps Buy Rating

MT Newswires Live

Nigeria's Jumia Q2 Revenue Rises

Acumen Pharmaceuticals Q2 Net Loss Widens, Misses Analyst Estimates

Similarweb Q2 FY26 GAAP Operating Income Swings to USD 0.7 Million; Revenue Rises 9% to USD 77.2 Million

Acumen Pharmaceuticals, Inc. Q2 Income from Operations USD -32.556 Million Vs. IBES Estimate USD -24.6 Million

Ataibeckley Inc : Deutsche Bank Cuts to Hold from Buy

THOMSON REUTERS

TScan Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS

Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights

THOMSON REUTERS

Acumen Pharmaceuticals, Inc. Q2 Basic EPS USD -0.45

THOMSON REUTERS

TScan Therapeutics Q2 Net Income USD -30.359 Million

THOMSON REUTERS

Press Release: Similarweb Announces Second Quarter 2026 Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BK4539/news?page=48"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":707.6491,"timestamp":1787683445797,"preClose":685.7458,"halted":0,"volume":206587513,"delay":0,"changeRate":0.031941,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":21.90332,"latestTime":"08-25 14:44:05 EDT","open":685.6775,"high":707.92865,"low":683.1322,"amount":6725685542.303396,"amplitude":0.03616,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.436531,"peRate":156.391987,"turnoverRate":0.016028,"increases":72,"decrements":73,"flats":6,"marketCap":493094381477.375,"floatMarketCap":374452038677.875},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":707.92865,"amplitude":0.03616,"preClose":685.7458,"low":683.1322,"pbRate":"5.436531","latestPrice":707.58325,"volume":206635118,"delay":0,"open":685.6775,"prevYearClose":881.5255,"prevWeekClose":700.9769,"prevMonthClose":673.0273,"prevQuarterClose":742.922,"fiveDayClose":655.4622,"twentyDayClose":704.4272,"sixtyDayClose":779.4826,"secType":"PLATE","market":"US","turnoverRate":0.016031,"peRate":156.391987,"marketCap":493057582525.375,"floatMarketCap":374424201997.875,"timestamp":1787683449270,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":72,"down":73,"flat":9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:48,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658974638","title":"Local Bounti Q2 Revenue Rises on Higher Production and Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974638","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974638?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:30","pubTimestamp":1786534202,"startTime":"0","endTime":"0","summary":"Local Bounti Q2 revenue rises on higher production and salesOverviewU.S. indoor agriculture firm's Q2 revenue rose 14% yr/yr on higher production and salesQ2 adjusted EBITDA loss improved 17% yr/yr; n","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N4490EB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1721429402.USD","BK4083","GRWG","LU1721429741.USD","BK4557","BK4212","DOLE","BK4539","BK4189","LOCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974947","title":"Press Release: Nexxen Reports Record Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974947","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974947?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:30","pubTimestamp":1786534200,"startTime":"0","endTime":"0","summary":"-- Record Q2 programmatic revenue of $95.2 million, up 12% year-over-year.-- All-time record quarterly CTV revenue of $37.8 million, up 33%. -- Programmatic revenue increased to 95% of total revenue, compared to 93%. -- CTV revenue increased to 40% of programmatic revenue, compared to 33% in. -- Video revenue represented 70% of programmatic revenue, compared to 68% in. compared to $29.9 million and a 34% Adjusted EBITDA margin on a. year-over-year change in Adjusted EBITDA primarily reflects increased. platform capabilities to support the Company's long-term growth. opportunities, as well as the impact of foreign currency exchange. million available under the Company's undrawn revolving credit facility. performance, as well as the collection of receivables in Q2 2026 that. were outstanding at the end of Q1 2026.\"We once again exceeded consensus expectations, delivering record Q2 Contribution ex-TAC and programmatic revenue, highlighted by all-time record quarterly CTV revenue which inc","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4009","AGIX","QTOC","AIPO","ARTY","NEXN","CHAT","BK4539","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658908970","title":"Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2658908970","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658908970?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:30","pubTimestamp":1786534200,"startTime":"0","endTime":"0","summary":"Received FDA clearance of IND application for XTX501, a potential best-in-class bispecific PD-1 / masked IL-2 Advancing IND-enabling studies for potential first-in-class multi-specific, masked T cell ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/12/3343546/0/en/xilio-therapeutics-reports-second-quarter-2026-financial-results-and-provides-pipeline-and-business-updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4139","BK4007","IND","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658971054","title":"Unicycive Therapeutics Q2 EPS USD -0.06","url":"https://stock-news.laohu8.com/highlight/detail?id=2658971054","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658971054?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:20","pubTimestamp":1786533640,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLXSW5DRH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","UNCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658971778","title":"Unicycive Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2658971778","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658971778?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:19","pubTimestamp":1786533580,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA96DVLX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","UNCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658710919","title":"Unicycive Therapeutics - Q2 Net Loss was $1.70 Mln or $0.06 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2658710919","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658710919?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:19","pubTimestamp":1786533580,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA96DVLX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["UNCY","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658971732","title":"Similarweb Q2 Revenue USD 77.186 Million Vs. IBES Estimate USD 75.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658971732","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658971732?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:17","pubTimestamp":1786533472,"startTime":"0","endTime":"0","summary":"Aug 12 (Reuters) - Similarweb Q2 income from operations USD 744 thousand.:((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))Source Date/Time = 12-AUG-202611:01:01.03 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nRSD5Q1myc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK4539","SMWB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658997141","title":"Similarweb Beats Q2 Estimates on AI Demand, Lifts FY Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997141","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658997141?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:11","pubTimestamp":1786533068,"startTime":"0","endTime":"0","summary":"Similarweb beats Q2 estimates on AI demand, lifts FY outlookOverviewDigital data analytics firm's Q2 revenue rose 9% yr/yr, beating analyst expectationsCompany posted first ever positive GAAP operatin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N4490DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2065171402.SGD","MNDY","BK4023","SMWB","LU2065170008.USD","LU2065169927.USD","BK4167","DH","LU1548497426.USD","BK4097","LU1720051108.HKD","ALLT","LU2357305700.SGD","BK4613","LU2065171311.SGD","BK4585","LU1720051017.SGD","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658971456","title":"Sutro Biopharma Q2 Revenue Misses Estimates, Posts Wider Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658971456","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658971456?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:10","pubTimestamp":1786533039,"startTime":"0","endTime":"0","summary":"Sutro Biopharma Q2 revenue misses estimates, posts wider lossOverviewU.S. oncology drug developer's Q2 revenue fell and missed analyst expectationsCompany posted a wider net loss for Q2Early STRO-004 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N4490DK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OLMA","STTK","BK4505","BK4139","BK4539","ERAS","STRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658971457","title":"BTIG Adjusts Price Target on AppLovin to $408 From $574, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2658971457","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658971457?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:09","pubTimestamp":1786532990,"startTime":"0","endTime":"0","summary":"AppLovin (APP) has an average rating of buy and mean price target of $563.03, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0154236417.USD","LU2063271972.USD","IE00BZ9MQY76.HKD","CLOD","XDAT","BK4608","BK4009","LU2360106780.USD","LU2250418816.HKD","LU0097036916.USD","LU2290526834.HKD","BK4585","LU2087625088.SGD","LU0056508442.USD","APPX","LU0353189763.USD","IE00B19Z9P08.USD","BK4588","LU1861215975.USD","IE00B19Z9Z06.USD","LU2360107168.USD","LU0353189680.USD","BK4023","LU1852331112.SGD","BK4613","APP","BK4539","IE00B894F039.SGD","LU1861220033.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658119971","title":"Nigeria's Jumia Q2 Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2658119971","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658119971?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:09","pubTimestamp":1786532977,"startTime":"0","endTime":"0","summary":"Nigeria's Jumia Q2 revenue risesOverviewAfrica e-commerce platform's Q2 revenue grew 14% yr/yr amid resilient demand and marketplace shiftQ2 adjusted EBITDA loss narrowed 36% yr/yr, reflecting improve","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N4490DG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4220","GLBE","HOUR","BK4539","BK4585","JMIA","BK4522","BK4122","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658971158","title":"Acumen Pharmaceuticals Q2 Net Loss Widens, Misses Analyst Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2658971158","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658971158?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:08","pubTimestamp":1786532883,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals Q2 net loss widens, misses analyst estimatesOverviewUS Alzheimer's therapeutics developer's Q2 net loss missed analyst expectationsQ2 loss from operations also missed analyst es","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N4490DJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","ABOS","GANX","COYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658560971","title":"Similarweb Q2 FY26 GAAP Operating Income Swings to USD 0.7 Million; Revenue Rises 9% to USD 77.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658560971","media":"Reuters","labels":["corporation","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658560971?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:02","pubTimestamp":1786532573,"startTime":"0","endTime":"0","summary":"Similarweb Q2 FY26 GAAP operating income swings to USD 0.7 million; revenue rises 9% to USD 77.2 millionSimilarweb Q2 revenue rose 9% to USD 77.2 million; GAAP operating income swung to USD 0.7 millio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL2V2BrD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK4539","SMWB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658971547","title":"Acumen Pharmaceuticals, Inc. Q2 Income from Operations USD -32.556 Million Vs. IBES Estimate USD -24.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658971547","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658971547?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:01","pubTimestamp":1786532461,"startTime":"0","endTime":"0","summary":"BRIEF-Acumen Pharmaceuticals, Inc. Q2 Income From Operations USD -32.556 Million Vs. IBES Estimate USD -24.6 MillionAug 12 (Reuters) - Acumen Pharmaceuticals, Inc. Q2 operating expenses USD 32.556 million.Q2 basic EPS USD -0.45Q2 net income USD -32.718 million vs. IBES estimate USD -23.3 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLXBFG93L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658971894","title":"Ataibeckley Inc : Deutsche Bank Cuts to Hold from Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2658971894","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658971894?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:00","pubTimestamp":1786532408,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nAQN2MEADK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","ATAI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658718139","title":"TScan Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2658718139","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658718139?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:00","pubTimestamp":1786532402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUAZ2FCS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","TCRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658718219","title":"Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2658718219","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658718219?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:00","pubTimestamp":1786532401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA85VZWN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","ABOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658971834","title":"Acumen Pharmaceuticals, Inc. Q2 Basic EPS USD -0.45","url":"https://stock-news.laohu8.com/highlight/detail?id=2658971834","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658971834?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:00","pubTimestamp":1786532401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLXBFG93L:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","ABOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658971889","title":"TScan Therapeutics Q2 Net Income USD -30.359 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658971889","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658971889?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:00","pubTimestamp":1786532401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLXCJGKNG:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","TCRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658979027","title":"Press Release: Similarweb Announces Second Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658979027","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658979027?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:00","pubTimestamp":1786532400,"startTime":"0","endTime":"0","summary":"Raising full-year guidance on strong AI demand and more than $60M in new contractsRevenue and Non-GAAP operating profit above the guidance rangeFirst ever quarter of positive GAAP operating profitOverall NRR increased to 100%TEL AVIV, Israel----August 12, 2026--Similarweb Ltd.  , a leading digital data and analytics company powering critical business decisions, today announced financial results for its second quarter ended June 30, 2026.\"We delivered a strong second quarter that I believe marks an important inflection point for Similarweb, with revenue and profit ahead of our expectations,\" stated Or Offer, Co-Founder and CEO of Similarweb. \"NRR increased to 100% for all customers, and we signed three seven-figure multi-year contracts worth more than $60 million combined, including an expansion that made a leading big tech customer our third eight-figure ARR account.\" Offer concluded, \"Commercial demand for our AI-related data and solutions is strong, and an expanding pipeline of oppor","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","CHAT","AGIX","AIPO","BK4023","ARTY","QTOC","VTHR","SMWB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":54,"pageCount":48,"totalSize":1076,"code":"91000000","status":"200"}]}}